news 2020
« BACK
Pharmacology - Health - 16.01.2020
Pharmacology - Health - 16.01.2020
Pharmacology - Health - 15.01.2020
Health - Pharmacology - 14.01.2020
Pharmacology - Health - 07.01.2020
Health - Pharmacology - 07.01.2020
Health - Pharmacology - 02.01.2020
Pharmacology
Results 181 - 187 of 187.
Cheap roundworm drug found to enhance the effects of chemotherapy in prostate cancer
Scientists at the University of Glasgow and Cancer Research UK Beatson Institute have tested close to 1000 existing medicines and discovered that a cheap drug commonly used to treat parasitic worm infection could be a game-changing treatment for prostate cancer. Prostate cancer is the most common cancer affecting men and the second most common cause of cancer death for men in the UK.
Scientists at the University of Glasgow and Cancer Research UK Beatson Institute have tested close to 1000 existing medicines and discovered that a cheap drug commonly used to treat parasitic worm infection could be a game-changing treatment for prostate cancer. Prostate cancer is the most common cancer affecting men and the second most common cause of cancer death for men in the UK.
Patients needed for irritable bowel syndrome trial
Patients in GP surgeries in Bristol are being invited to take part in a large trial of low-dose amitriptyline for irritable bowel syndrome (IBS) lead by researchers from the universities of Bristol, Leeds and Southampton. IBS is a common gut disorder affecting one in ten people. Abdominal pain, bloating, and altered bowel habit affect patients' quality of life substantially and can force them to take days off work.
Patients in GP surgeries in Bristol are being invited to take part in a large trial of low-dose amitriptyline for irritable bowel syndrome (IBS) lead by researchers from the universities of Bristol, Leeds and Southampton. IBS is a common gut disorder affecting one in ten people. Abdominal pain, bloating, and altered bowel habit affect patients' quality of life substantially and can force them to take days off work.
Stepping up to the challenge: studying drug dosage during an Ebola outbreak
A specialist technique used to study drugs has been completed for the first time during an outbreak of Ebola virus disease. The study published today in eBiomedicine was a collaboration of researchers from Sierra Leone and the University's of Glasgow, Oxford, Cambridge and the Liverpool School of Tropical Medicine.
A specialist technique used to study drugs has been completed for the first time during an outbreak of Ebola virus disease. The study published today in eBiomedicine was a collaboration of researchers from Sierra Leone and the University's of Glasgow, Oxford, Cambridge and the Liverpool School of Tropical Medicine.
Routine HIV screening in general practice boosts testing and early diagnosis
Offering HIV screening to new patients in general practice on a routine basis increases testing rates and improves detection and earlier diagnosis, according to research co-led by UCL and Queen Mary University of London HIV testing rates in general practice are low, despite testing being recommended in UK and international guidelines.
Offering HIV screening to new patients in general practice on a routine basis increases testing rates and improves detection and earlier diagnosis, according to research co-led by UCL and Queen Mary University of London HIV testing rates in general practice are low, despite testing being recommended in UK and international guidelines.
Brain tumour research could help future precision medicine
New research on brain tumours could improve patient diagnosis and treatment options as part of a precision medicine approach. Brain tumours are the leading cause of cancer deaths in children and adults under the age of 40, with 16,000* people in the UK diagnosed with a brain tumour each year. The study led by the Brain Tumour Research Centre at the University of Bristol in collaboration with the Cancer Research and Cell Biology (CCRCB) at Queen's University Belfast investigated the genetics of brain tumours.
New research on brain tumours could improve patient diagnosis and treatment options as part of a precision medicine approach. Brain tumours are the leading cause of cancer deaths in children and adults under the age of 40, with 16,000* people in the UK diagnosed with a brain tumour each year. The study led by the Brain Tumour Research Centre at the University of Bristol in collaboration with the Cancer Research and Cell Biology (CCRCB) at Queen's University Belfast investigated the genetics of brain tumours.
Marathon running makes arteries younger and lowers blood pressure
The new year means it's time to set resolutions for 2020, and new research led by UCL and Barts Health NHS Trust suggests running a marathon for the first time could have several health benefits. The study, published by the Journal of the American College of Cardiology, found that for first-time marathon runners, training and completion of the marathon resulted in reductions in blood pressure and aortic stiffening in healthy participants that were equivalent to a four-year reduction in vascular age.
The new year means it's time to set resolutions for 2020, and new research led by UCL and Barts Health NHS Trust suggests running a marathon for the first time could have several health benefits. The study, published by the Journal of the American College of Cardiology, found that for first-time marathon runners, training and completion of the marathon resulted in reductions in blood pressure and aortic stiffening in healthy participants that were equivalent to a four-year reduction in vascular age.
Finds new non-invasive technique to assess brain tumours in children and make treatment less toxic
Ground-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhood brain tumours. Funded by Children with Cancer UK , Action Medical Research and The Brain Tumour Charity , the study is the first of its kind and will allow clinicians to give more personalised treatments for childhood brain cancers, which currently account for one third of all childhood cancer deaths in the UK.
Ground-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhood brain tumours. Funded by Children with Cancer UK , Action Medical Research and The Brain Tumour Charity , the study is the first of its kind and will allow clinicians to give more personalised treatments for childhood brain cancers, which currently account for one third of all childhood cancer deaths in the UK.
